4th Quarter - Termination — SOCIETY FOR CARDIOVASCULAR ANGIOGRAPHY… for SOCIETY FOR CARDIOVASCULAR ANGIOGRAPHY… (2016)

Firm

SOCIETY FOR CARDIOVASCULAR ANGIOGRAPHY AND INTERVENTIONS

Client

SOCIETY FOR CARDIOVASCULAR ANGIOGRAPHY AND INTERVENTIONS

Income

—

Expenses

$30,000

Expense method

A: Lobbying Disclosure Act definitions

Terminated

Oct 1, 2016

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing	Filed	Amount	Counted
4th Quarter - Report	Jan 18, 2017	$30,000	Replaced
4th Quarter - Amendment	Sep 28, 2017	$30,000	Replaced
4th Quarter - Amendment	Nov 6, 2017	$30,000	Replaced
4th Quarter - Termination (this page)	Nov 15, 2017	$30,000	Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Medicare PPACA Reform FDA Reform

Lobbyist	Covered position, as disclosed
WAYNE ALAN POWELL	—

Contacted: Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Coverage and Payment for Physician Services

Lobbyist	Covered position, as disclosed
WAYNE ALAN POWELL	—

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Medical/Disease Research/Clinical Labs MED

FDA Device Review Process etc

Lobbyist	Covered position, as disclosed
WAYNE ALAN POWELL	—

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.